|
D-Glucose monohydrate for injectable solutions.
White, odourless, sweet tasting crystalline powder, freely soluble in water.
- Pharmacopoeia conformity
- European Pharmacopoeia
- USP / NF
- GMP
- Manufacturing plant compliant with cGMP/FDA and GMP/ICH Q7A quality guidelines
CEP: R2CEP1996-030
US DMF type II n° 4697 (Lestrem plant)
US DMF type II n° 11059 (Keokuk plant)
A CTD-format document with LYCADEX® PF information can be obtained under confidentiality agreement.
|
Double control:
- Assay for endotoxins (L.A.L. test)
- Detection of pyrogenic substances (rabbit test)
High filterability:
The high filterability of LYCADEX® PF extends the lifetime of filters and saves extra production costs caused by clogging
- Osmotic agent in injectable solutions and dialysis solutions
- Energy source for parenteral nutrition
- Treatment of hypoglycaemia
|